Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Feb-24 5:40 PM View:  | Neurocrine Biosciences Inc. (NBIX) | 13-Feb-24 | Private Sale (Planned) | 1,352 | $132.90 | $179,674.00 | (< 1%) 136.52K to 135.17K | |
| 08-Feb-24 7:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-24 | Sale (Planned) | 980 | $134.20 | $131,519.00 | (< 1%) 134.93K to 133.95K | |
| 08-Feb-24 7:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-24 | Private Sale (Planned) | 1,600 | $142.20 | $227,522.00 | (1%) 134.67K to 133.07K | |
| 02-Feb-24 7:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-24 | Private Sale (Planned) | 1,541 | $140.70 | $216,813.00 | (1%) 133.18K to 131.63K | |
| 04-Jan-24 6:32 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Jan-24 | Option Exercise | 75,000 | $19.59 | $1,469,250.00 | 58% 130.25K to 205.25K | |
| 04-Jan-24 6:32 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Jan-24 | Planned Option Sale | 75,000 | $131.47 | $9,860,200.00 | (37%) 205.25K to 130.25K | |
| 23-Aug-23 8:05 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Aug-23 | Private Sale (Planned) | 2,132 | $107.41 | $228,993.00 | (2%) 132.38K to 130.25K | |
| 08-Feb-23 7:25 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-23 | Sale (Planned) | 980 | $103.99 | $101,910.00 | (< 1%) 129.08K to 128.1K | |
| 08-Feb-23 7:25 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-23 | Sale (Planned) | 14,424 | $102.40 | $1,476,980.00 | (10%) 141.64K to 127.22K | |
| 08-Feb-23 7:25 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-23 | Private Sale (Planned) | 1,600 | $105.64 | $169,028.00 | (1%) 115.86K to 114.26K | |
| 02-Feb-23 5:15 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-23 | Private Sale (Planned) | 1,541 | $109.99 | $169,486.00 | (1%) 114.36K to 112.82K | |
| 09-Feb-22 6:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-22 | Sale (Planned) | 980 | $79.67 | $78,078.60 | (< 1%) 112.15K to 111.17K | |
| 09-Feb-22 6:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-22 | Private Sale (Planned) | 5,900 | $80.77 | $476,549.00 | (5%) 116.19K to 110.29K | |
| 07-Jan-22 6:04 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Jan-22 | Option Exercise | 28,266 | $8.66 | $244,784.00 | 27% 104.98K to 133.25K | |
| 07-Jan-22 6:04 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Jan-22 | Market Option Sale (Planned) | 28,266 | $85.50 | $2,416,750.00 | (21%) 133.25K to 104.98K | |
| 09-Feb-21 9:42 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-21 | Market Sale (Planned) | 3,693 | $116.85 | $431,518.00 | (3%) 108.46K to 104.77K | 1% |
| 09-Feb-21 9:42 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-21 | Market Sale (Planned) | 2,677 | $114.00 | $305,184.00 | (3%) 103.12K to 100.44K | (1%) |
| 16-Nov-20 6:11 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Nov-20 | Market Sale (Planned) | 2,257 | $90.73 | $204,770.00 | (2%) 100.28K to 98.03K | (27%) |
| 07-Aug-20 7:24 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Aug-20 | Market Sale (Planned) | 2,257 | $118.87 | $268,286.00 | (2%) 98.25K to 96.0K | 3% |
| 28-Apr-20 8:40 PM View: | Neurocrine Biosciences Inc. (NBIX) | 24-Apr-20 | Market Sale (Planned) | 1,934 | $99.47 | $192,377.00 | (2%) 95.9K to 93.97K | (16%) |
| 11-Feb-20 7:13 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-20 | Market Sale (Planned) | 1,623 | $103.33 | $167,710.00 | (2%) 93.6K to 91.97K | (12%) |
| 07-Feb-20 6:54 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-20 | Market Sale (Planned) | 1,000 | $101.41 | $101,413.00 | (1%) 91.51K to 90.51K | (14%) |
| 07-Feb-20 6:54 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-20 | Market Sale (Planned) | 3,690 | $103.05 | $380,262.00 | (4%) 93.3K to 89.61K | (12%) |
| 08-Feb-19 5:07 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-19 | Market Sale (Planned) | 762 | $83.56 | $63,672.60 | (< 1%) 86.59K to 85.83K | (38%) |
| 06-Feb-19 6:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-19 | Market Sale (Planned) | 2,434 | $88.12 | $214,482.00 | (3%) 87.13K to 84.69K | (31%) |
| 06-Feb-19 6:03 PM View: | Neurocrine Biosciences Inc. (NBIX) | 04-Feb-19 | Market Sale (Planned) | 1,375 | $88.14 | $121,186.00 | (2%) 81.49K to 80.12K | (31%) |
| 03-Aug-18 4:08 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Aug-18 | Option Exercise | 28,266 | $8.66 | $244,784.00 | 36% 78.74K to 107.01K | |
| 03-Aug-18 4:08 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Aug-18 | Market Option Sale (Planned) | 28,266 | $115.00 | $3,250,590.00 | (26%) 107.01K to 78.74K | (< 1%) |
| 07-Mar-18 4:16 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Mar-18 | Option Exercise | 23,650 | $8.65 | $204,572.00 | 30% 78.74K to 102.39K | |
| 07-Mar-18 4:16 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Mar-18 | Market Option Sale (Planned) | 23,650 | $90.00 | $2,128,500.00 | (23%) 102.39K to 78.74K | (28%) |
| 07-Feb-18 5:59 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-18 | Payment of Exercise | 658 | $82.48 | $54,271.80 | (< 1%) 80.1K to 79.45K | (40%) |
| 07-Feb-18 5:59 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-18 | Market Sale (Planned) | 2,046 | $83.05 | $169,914.00 | (3%) 80.25K to 78.2K | (39%) |
| 18-Jan-18 4:08 PM View: | Neurocrine Biosciences Inc. (NBIX) | 16-Jan-18 | Market Sale (Planned) | 1,625 | $79.05 | $128,460.00 | (2%) 76.5K to 74.87K | (46%) |
| 06-Nov-17 4:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Nov-17 | Option Exercise | 24,818 | $8.66 | $214,810.00 | 34% 73.25K to 98.06K | |
| 06-Nov-17 4:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Nov-17 | Market Option Sale (Planned) | 24,818 | $71.05 | $1,763,320.00 | (25%) 98.06K to 73.25K | (63%) |
| 08-Sep-17 2:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Sep-17 | Option Exercise | 4,607 | $8.65 | $39,850.50 | 6% 73.25K to 77.85K | |
| 03-Oct-17 7:13 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Sep-17 | Option Exercise | 20,393 | $8.65 | $176,399.00 | 28% 73.25K to 93.64K | |
| 08-Sep-17 2:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Sep-17 | Market Option Sale (Planned) | 4,607 | $60.00 | $276,420.00 | (6%) 77.85K to 73.25K | (93%) |
| 03-Oct-17 7:13 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Sep-17 | Market Option Sale (Planned) | 20,393 | $60.00 | $1,223,580.00 | (22%) 93.64K to 73.25K | (93%) |
| 03-May-17 6:41 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-May-17 | Option Exercise | 15,000 | $2.59 | $38,850.00 | 20% 73.25K to 88.25K | |
| 03-May-17 6:41 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-May-17 | Market Option Sale (Planned) | 15,000 | $54.00 | $810,000.00 | (17%) 88.25K to 73.25K | (114%) |
| 13-Apr-17 4:53 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Apr-17 | Market Sale (Planned) | 13,065 | $50.42 | $658,774.00 | (15%) 86.31K to 73.25K | (129%) |
| 08-Feb-17 7:42 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-17 | Market Sale (Planned) | 727 | $43.15 | $31,370.10 | (1%) 62.04K to 61.31K | (168%) |
| 06-Feb-17 7:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Feb-17 | Market Sale (Planned) | 1,375 | $42.57 | $58,533.80 | (2%) 61.49K to 60.11K | (172%) |
| 18-Jan-17 6:44 PM View: | Neurocrine Biosciences Inc. (NBIX) | 17-Jan-17 | Market Sale (Planned) | 1,625 | $40.65 | $66,056.20 | (3%) 60.36K to 58.74K | (184%) |
| 12-Jan-17 7:00 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Jan-17 | Market Sale (Planned) | 1,250 | $43.37 | $54,212.50 | (2%) 58.36K to 57.11K | (167%) |
| 13-Apr-16 8:46 PM View: | Neurocrine Biosciences Inc. (NBIX) | 11-Apr-16 | Option Exercise | 41,770 | $5.76 | $240,595.00 | 75% 55.86K to 97.63K | |
| 13-Apr-16 8:46 PM View: | Neurocrine Biosciences Inc. (NBIX) | 11-Apr-16 | Market Option Sale (Planned) | 41,770 | $44.02 | $1,838,510.00 | (43%) 97.63K to 55.86K | (163%) |
| 04-Feb-16 7:23 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Feb-16 | Market Sale (Planned) | 1,375 | $37.98 | $52,222.50 | (2%) 57.24K to 55.86K | (204%) |
| 21-Jan-16 4:13 PM View: | Neurocrine Biosciences Inc. (NBIX) | 19-Jan-16 | Market Sale (Planned) | 1,625 | $46.84 | $76,115.00 | (3%) 56.11K to 54.49K | (147%) |